• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur J Public Health . SARS-CoV-2 testing uptake and its determinants in six ethnic groups living in Amsterdam, the Netherlands: a registry-based st

tetano

Editor, Senior Moderator
Eur J Public Health


. 2026 Jun 10;36(4):ckag081.
doi: 10.1093/eurpub/ckag081.
SARS-CoV-2 testing uptake and its determinants in six ethnic groups living in Amsterdam, the Netherlands: a registry-based study within the HELIUS cohort

Sophie L Campman[SUP] 1 2 3 [/SUP], Anders Boyd[SUP] 1 2 3 4 [/SUP], Nina van Wilgen[SUP] 1 [/SUP], Felix P Chilunga[SUP] 5 6 [/SUP], Liza Coyer[SUP] 1 2 3 [/SUP], Janke Schinkel[SUP] 7 [/SUP], Charles Agyemang[SUP] 5 8 [/SUP], Henrike Galenkamp[SUP] 5 6 [/SUP], Anitra D M Koopman[SUP] 5 6 [/SUP], Jelle Koopsen[SUP] 1 [/SUP], Matthijs Welkers[SUP] 1 [/SUP], Karien Stronks[SUP] 5 6 [/SUP], Maria Prins[SUP] 1 2 3 [/SUP]


Affiliations
Abstract

Diagnostic testing was key in preventing transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the pre-vaccination era of the coronavirus disease 2019 pandemic. This study compared SARS-CoV-2 polymerase chain reaction (PCR) testing uptake and its determinants across six ethnic groups in Amsterdam, the Netherlands. We analyzed data from the population-based Healthy Life in an Urban Setting cohort linked to SARS-CoV-2 testing registry data from the Public Health Service of Amsterdam. Testing uptake was defined as completing at least one SARS-CoV-2 PCR test before 6 September 2021. We examined the association between ethnicity and testing uptake, and assessed determinants of testing uptake per ethnic group, using logistic regression while correcting for ethnic-specific age and sex distributions in Amsterdam. We included 19 006 participants (median age 53 years; 57% female). Testing uptake ranged from 25.3% (95% confidence interval (CI) = 23.1%-27.5%) in the Ghanaian to 52.2% (95% CI = 50.3%-54.1%) in the Turkish group. Individuals of Turkish origin [adjusted odds ratio (aOR) = 1.12, 95% CI = 1.01-1.23] were more likely, while those of African Surinamese (aOR = 0.88, 95% CI = 0.79-0.97) and particularly Ghanaian (aOR = 0.35, 95% CI = 0.30-0.40) origin less likely to be tested compared to those of Dutch origin. Younger age and perceived work or home-related stress were associated with testing uptake across most ethnic groups. Other determinants were specific to certain groups. SARS-CoV-2 testing uptake varied slightly across most ethnic groups in Amsterdam with the highest uptake among individuals of Turkish origin but was remarkably lower among individuals of Ghanaian origin. Given the diversity of identified determinants, testing strategies should be tailored to the needs of specific groups.

Keywords: COVID-19; PCR; SARS-CoV-2; ethnicity; testing uptake.

 
Back
Top